StonvexLoading…
StonvexStonvexStonvexCore line items from PDFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $60.13M | $219.02M | $156.62M | $99.51M |
Operating Income | $6.31M | $5.85M | $2.39M | $-2.44M |
Net Income | $4.79M | $-640.00K | $-592.00K | $-1.89M |
EPS (Diluted) | $0.12 | $-0.02 | $-0.02 | $-0.05 |
Total Assets | $430.56M | $418.70M | $406.40M | $391.13M |
Total Liabilities | $150.10M | $147.68M | $142.02M | $133.61M |
Cash & Equivalents | $31.15M | $42.22M | $35.88M | $37.41M |
Free Cash Flow OCF − CapEx | $-8.80M | $-8.58M | $-16.13M | $-13.23M |
Shares Outstanding | 39.91M | 39.54M | 39.51M | 39.16M |